Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Beike Biotech Given $1.8 Million Grant for Umbilical Cord Stem Cell Trial

publication date: Jan 11, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shenzhen Beike Biotechnology Co. has received a $1.8 million grant to conduct a clinical trial of human umbilical cord mesenchymal stem cells (hUC-MSC) as a treatment for Systemic Lupus Erythematosus (SLE), Multiple Sclerosis (MS) and other degenerative diseases. The grant was awarded by Jiangsu’s Department of Science and Technology. Beike Biotech’s partners in the project are Jiangsu University and Nanjing University’s Drug Tower Hospital. More details...



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners